[Low cholesterol level--symptom of a disease?] by Karpe, F, Regnström, J, Tornvall, P

Low cholesterol level--symptom of a disease? by Karpe, F, Regnström, J, Tornvall, P

[Can cholesterol lowering treatment have unwanted effects?] by Karpe, F, Regnström, J, Tornvall, P

REMNANT LIPOPROTEINS AND CORONARY ARTERY DISEASE PROGRESSION by Karpe, F, Tornvall, P, Hamsten, A

Can cholesterol lowering treatment have unwanted effects? by Karpe, F, Regnström, J, Tornvall, P

Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. by Tornvall, P, Karpe, F, Carlson, L, Hamsten, A

Postprandial very low density lipoproteins: Composition and cellular interactions by Bjorkegren, J, Karpe, F, Tornvall, P, Hamsten, A

Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. by Tornvall, P, Olivecrona, G, Karpe, F, Hamsten, A, Olivecrona, T

Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro. by Björkegren, J, Karpe, F, Vitols, S, Tornvall, P, Hamsten, A

HYPERTRIGLYCERIDEMIA, TRIGLYCERIDE-RICH LIPOPROTEINS, AND CORONARY ATHEROSCLEROSIS by Hamsten, A, Tornvall, P, Johansson, J, Karpe, F, Carlson, L

Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. by Karpe, F, Tornvall, P, Olivecrona, T, Steiner, G, Carlson, L, Hamsten, A

Triglycerides and postprandial angina - Response by Lundman, P, Tornvall, P, Eriksson, M, Schenck-Gustafsson, K, Karpe, F

Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. by Lundman, P, Eriksson, M, Schenck-Gustafsson, K, Karpe, F, Tornvall, P

Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. by Fatah, K, Silveira, A, Tornvall, P, Karpe, F, Blombäck, M, Hamsten, A

Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype. by Båvenholm, P, Karpe, F, Proudler, A, Tornvall, P, Crook, D, Hamsten, A

In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low-density lipoproteins. by Skoglund-Andersson, C, Karpe, F, Hellénius, M, Regnström, J, Hamsten, A, Tornvall, P

High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease. by Tornvall, P, Karpe, F, Proudler, A, Båvenholm, P, Landou, C, Olivecrona, T, Hamsten, A

A decrease in cardiovascular risk factors in healthy 40-year-old Swedish men between 1980-1983 and 1991-1992. by Tornvall, P, Båvenholm, P, Hellénius, M, Karpe, F, Regnström, J, de Faire, U

Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial i... by Bennermo, M, Held, C, Green, F, Strandberg, L, Ericsson, C, Hansson, L, Watkins, H, Hamsten, A, Tornvall, P

A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. by Kovacs, A, Green, F, Hansson, L, Lundman, P, Samnegård, A, Boquist, S, Ericsson, C, Watkins, H, Hamsten, A, Tornvall, P